Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market definition
1.3 Forecast parameters
1.4 Data sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Unpaid sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Healthcare 3D printing industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Technology trends
2.1.4 Application trends
2.1.5 Regional trends
Chapter 3 Healthcare 3D Printing Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Technological advancements
3.3.1.2 Extended clinical applications
3.3.1.3 Increasing demand for custom implants
3.3.1.4 Increasing R&D investments from manufacturers and institutions
3.3.2 Industry pitfalls & challenges
3.3.2.1 Lack of skilled professionals
3.3.2.2. High price associated with 3 D printing
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By technology
3.4.3 By application
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis
4.3 Strategic dashboard
Chapter 5 Healthcare 3D Printing Market, By Product
5.1 Key segment trends
5.2 Syringe based,
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Magnetic levitation
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Laser based
5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Inkjet based
5.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Healthcare 3D Printing Market, By Technology
6.1 Key segment trends
6.2 Fused deposition modelling (FDM)
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Selective laser sintering (SLS)
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Stereolithography
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Others
6.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Healthcare 3D Printing Market, By Application
7.1 Key segment trends
7.2 Biosensors
7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Medical
7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.3.2 Pharmaceuticals
7.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3.3 Prosthetics and implants
7.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.3.4 Tissue and organ generation
7.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Dental
7.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Healthcare 3D Printing Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2018 - 2032 (USD Million)
8.2.2 Market size, by product, 2018 - 2032 (USD Million)
8.2.3 Market size, by technology, 2018 - 2032 (USD Million)
8.2.4 Market size, by application, 2018 - 2032 (USD Million)
8.2.4.1 Market size, by medical, 2018 - 2032 (USD Million)
8.2.5 U.S.
8.2.5.1 Market size, by product, 2018 - 2032 (USD Million)
8.2.5.2 Market size, by technology, 2018 - 2032 (USD Million)
8.2.5.3 Market size, by application, 2018 - 2032 (USD Million)
8.2.5.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.2.6 Canada
8.2.6.1 Market size, by product, 2018 - 2032 (USD Million)
8.2.6.2 Market size, by technology, 2018 - 2032 (USD Million)
8.2.6.3 Market size, by application, 2018 - 2032 (USD Million)
8.2.6.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2018 - 2032 (USD Million)
8.3.2 Market size, by product, 2018 - 2032 (USD Million)
8.3.3 Market size, by technology, 2018 - 2032 (USD Million)
8.3.4 Market size, by application, 2018 - 2032 (USD Million)
8.3.4.1 Market size, by medical, 2018 - 2032 (USD Million)
8.3.5 Germany
8.3.5.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.5.2 Market size, by technology, 2018 - 2032 (USD Million)
8.3.5.3 Market size, by application, 2018 - 2032 (USD Million)
8.3.5.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.3.6 UK
8.3.6.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.6.2 Market size, by technology, 2018 - 2032 (USD Million)
8.3.6.3 Market size, by application, 2018 - 2032 (USD Million)
8.3.6.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.3.7 France
8.3.7.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.7.2 Market size, by technology, 2018 - 2032 (USD Million)
8.3.7.3 Market size, by application, 2018 - 2032 (USD Million)
8.3.7.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.3.8 Italy
8.3.8.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.8.2 Market size, by technology, 2018 - 2032 (USD Million)
8.3.8.3 Market size, by application, 2018 - 2032 (USD Million)
8.3.8.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.9.2 Market size, by technology, 2018 - 2032 (USD Million)
8.3.9.3 Market size, by application, 2018 - 2032 (USD Million)
8.3.9.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.3.10 Russia
8.3.10.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.10.2 Market size, by technology, 2018 - 2032 (USD Million)
8.3.10.3 Market size, by application, 2018 - 2032 (USD Million)
8.3.10.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2018 - 2032 (USD Million)
8.4.2 Market size, by product, 2018 - 2032 (USD Million)
8.4.3 Market size, by technology, 2018 - 2032 (USD Million)
8.4.4 Market size, by application, 2018 - 2032 (USD Million)
8.4.4.1 Market size, by medical, 2018 - 2032 (USD Million)
8.4.5 Japan
8.4.5.1 Market size, by product, 2018 - 2032 (USD Million)
8.4.5.2 Market size, by technology, 2018 - 2032 (USD Million)
8.4.5.3 Market size, by application, 2018 - 2032 (USD Million)
8.4.5.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.4.6 China
8.4.6.1 Market size, by product, 2018 - 2032 (USD Million)
8.4.6.2 Market size, by technology, 2018 - 2032 (USD Million)
8.4.6.3 Market size, by application, 2018 - 2032 (USD Million)
8.4.6.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.4.7 India
8.4.7.1 Market size, by product, 2018 - 2032 (USD Million)
8.4.7.2 Market size, by technology, 2018 - 2032 (USD Million)
8.4.7.3 Market size, by application, 2018 - 2032 (USD Million)
8.4.7.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.4.8 Australia
8.4.8.1 Market size, by product, 2018 - 2032 (USD Million)
8.4.8.2 Market size, by technology, 2018 - 2032 (USD Million)
8.4.8.3 Market size, by application, 2018 - 2032 (USD Million)
8.4.8.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.4.9 South Korea
8.4.9.1 Market size, by product, 2018 - 2032 (USD Million)
8.4.9.2 Market size, by technology, 2018 - 2032 (USD Million)
8.4.9.3 Market size, by application, 2018 - 2032 (USD Million)
8.4.9.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2018 - 2032 (USD Million)
8.5.2 Market size, by product, 2018 - 2032 (USD Million)
8.5.3 Market size, by technology, 2018 - 2032 (USD Million)
8.5.4 Market size, by application, 2018 - 2032 (USD Million)
8.5.4.1 Market size, by medical, 2018 - 2032 (USD Million)
8.5.5 Brazil
8.5.5.1 Market size, by product, 2018 - 2032 (USD Million)
8.5.5.2 Market size, by technology, 2018 - 2032 (USD Million)
8.5.5.3 Market size, by application, 2018 - 2032 (USD Million)
8.5.5.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.5.6 Mexico
8.5.6.1 Market size, by product, 2018 - 2032 (USD Million)
8.5.6.2 Market size, by technology, 2018 - 2032 (USD Million)
8.5.6.3 Market size, by application, 2018 - 2032 (USD Million)
8.5.6.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.5.7 Argentina
8.5.7.1 Market size, by product, 2018 - 2032 (USD Million)
8.5.7.2 Market size, by technology, 2018 - 2032 (USD Million)
8.5.7.3 Market size, by application, 2018 - 2032 (USD Million)
8.5.7.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.6 MEA
8.6.1 Market size, by country, 2018 - 2032 (USD Million)
8.6.2 Market size, by product, 2018 - 2032 (USD Million)
8.6.3 Market size, by technology, 2018 - 2032 (USD Million)
8.6.4 Market size, by application, 2018 - 2032 (USD Million)
8.6.4.1 Market size, by medical, 2018 - 2032 (USD Million)
8.6.5 South Africa
8.6.5.1 Market size, by product, 2018 - 2032 (USD Million)
8.6.5.2 Market size, by technology, 2018 - 2032 (USD Million)
8.6.5.3 Market size, by application, 2018 - 2032 (USD Million)
8.6.5.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.6.6 Saudi Arabia
8.6.6.1 Market size, by product, 2018 - 2032 (USD Million)
8.6.6.2 Market size, by technology, 2018 - 2032 (USD Million)
8.6.6.3 Market size, by application, 2018 - 2032 (USD Million)
8.6.6.3.1 Market size, by medical, 2018 - 2032 (USD Million)
Chapter 9 Company Profiles
9.1 Aprecia Pharmaceuticals
9.1.1 Business overview
9.1.2 Financial data
9.1.3 Product landscape
9.1.4 Strategic outlook
9.1.5 SWOT analysis
9.2 Aspect Biosystems
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Bio 3D Technologies
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 BioBots
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Cyfuse Biomedical
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 Digilab
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 3Dynamics Systems
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 Envision TEC
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Luxexel
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Materialise NV
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Nano3D Biosciences
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
9.12 Oceanz
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Product landscape
9.12.4 Strategic outlook
9.12.5 SWOT analysis
9.13 Organovo Holdings, Inc
9.13.1 Business overview
9.13.2 Financial data
9.13.3 Product landscape
9.13.4 Strategic outlook
9.13.5 SWOT analysis
9.14 regenHU
9.14.1 Business overview
9.14.2 Financial data
9.14.3 Product landscape
9.14.4 Strategic outlook
9.14.5 SWOT analysis
9.15 Renishaw
9.15.1 Business overview
9.15.2 Financial data
9.15.3 Product landscape
9.15.4 Strategic outlook
9.15.5 SWOT analysis
9.16 Solidscape
9.16.1 Business overview
9.16.2 Financial data
9.16.3 Product landscape
9.16.4 Strategic outlook
9.16.5 SWOT analysis
9.17 Stratasys Ltd
9.17.1 Business overview
9.17.2 Financial data
9.17.3 Product landscape
9.17.4 Strategic outlook
9.17.5 SWOT analysis
9.18 Tevido BioDevices
9.18.1 Business overview
9.18.2 Financial data
9.18.3 Product landscape
9.18.4 Strategic outlook
9.18.5 SWOT analysis
9.19 3D Bioprinting Solutions
9.19.1 Business overview
9.19.2 Financial data
9.19.3 Product landscape
9.19.4 Strategic outlook
9.19.5 SWOT analysis
9.20 3D Biotek
9.20.1 Business overview
9.20.2 Financial data
9.20.3 Product landscape
9.20.4 Strategic outlook
9.20.5 SWOT analysis
9.21 3D Systems Inc.
9.21.1 Business overview
9.21.2 Financial data
9.21.3 Product landscape
9.21.4 Strategic outlook
9.21.5 SWOT analysis
